Acquired Activated Protein C Resistance in Patients with Lupus Anticoagulant and Essential Thrombocythemia

Abstract

The prevalence of activated protein C (APC) resistance and the antigen levels of factor V were assessed in 37 patients with lupus anticoagulant (LA), 12 with essential thrombocythemia (ET), 17 with idiopathic thrombocytopenic purpura (ITP), and in 27 cases of thrombotic complications associated with diabetes mellitus and collagen vascular disease. Blood samples taken from 30 healthy normal subjects were also available for comparison. The mean APC ratio of patients with LA (2.9 ± 1.5), ET (2.7 ± 1.2), and secondary thrombosis (2.6 ± 0.9) were significantly lower than that of the healthy control group (3.5 ± 1.0). The APC ratio of ET patients with thrombosis (2.3 ± 0.6) was significantly lower than that measured in ET cases without thrombotic complication (3.9 ± 1.9). Patients positive for LA and with thrombotic complication (1.8 ± 1.4) presented lower APC ratios than those without thrombosis (3.3 ± 1.4). Among all patients, an APC ratio lower than 2 was found in 24 cases, of which 16 had thrombotic disease, but none of them presented the factor V:R506Q mutation. The antigen levels of factor V correlated significantly with APC ratio in all patients. The results of this investigation suggest that an acquired poor anticoagulant response to APC might explain, at least in part, the thrombophilia of patients with LA and ET and that associated with diabetes mellitus or collagen disease. Key Words: APC resistance—Lupus anticoagulant—Essential thrombocythemia.

Get full access to this article

View all access options for this article.

References

Schafer AL Bleeding and thrombosis in the myeloproliferative disorder. Blood 1984;64:1.

Mueh JR , Herbst KD , Rapaport ST Thrombosis in patients with the lupus anticoagulant. Ann Int Med 1980;92:156.

De Wolf F. , Carreras L. , Moerman P. , Vermylen J. , Assche AV , Renaer M. Decidual vasculopathy and extensive placental infarction. in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142:829-34.

Carreras LO , Machih SJ , Demah R. , et al. Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981;1:244.

Peck B. , Hoffman GS , Franck WA Thrombophlebitis in systemic lupus erythematosus. JAMA 1978;240:1728.

Paillole C. , Ruiz J. , Juliard JM , Leblanc H. , Gourgon R. , Passa PH Detection of coronary disease in diabetic patients. Diabetologia 1995;38,726-31.

Clouse LH , Comp PC The regulation of hemostasis. N Engl J Med 1986;314:1298.

Shen L. , Dahlback B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 1994 ;269: 18735.

Miletich JP , Prescott SM , White R. , Majerus PW , Bovill EG Inherited predisposition to thrombosis. Cell 1993;72:477.

10.

Dahlback B. , Carsson M. , Stevensson PJ Familial thrombophilia due to a previously unrecognized mechanism characterized by poor response to activated protein C. Proc Natl Acad Sci USA 1994;90:1004.

11.

Bertina RM , Koeleman Bpc , Koster T. , et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;169:64.

12.

Svensson PJ , Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330: 517.

13.

Mori T. , Takeya H. , Nishioka J. , Gabazza EC , Suzuki K. β2-glycoprotein modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb Haemostasis 1996;75:49-55.

14.

Bokarewa MI , Blomback M. , Egberg N. , Rosen S. A. new variant of interaction between phospholipid antibodies and the protein C system. Blood Coag Fibrinolysis 1993;5:37-41.

15.

Freyssinet JM , Cazenave JP Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis. Thromb Haemostasis 1987;58:679-81.

16.

Borret M. , Sala N. , Castellarnau CD , Lopez S. , Gari M. , Fontcuberta J. Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells. Thromb Haemostasis 1992;68:268-72.

17.

Armitage P. , Berry G. Statistical methods in medical research, 3rd ed. London: Blackwell Scientific Publications, 1994.

18.

Fujikawa K. , Suzuki K. Cellular coagulant and anticoagulant proteins. In: Poller L , ed. Recent advances in blood coagulation Edinburgh: Churchill Livingstone , 1991:35-51.

19.

De Ronde H. , Bertina RM Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria . Thromb Haemostasis, 1994;72: 880—6.

20.

Rosen S. , Johansson K. , Linberg K. , Dahlback B. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasma from healthy individuals. Thromb Haemostasis 1994;72:255.

21.

Takamiya O. , Ishida F. , Kodaira H. , Kitano K. APC-resistance and MnL I genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemostasis 1995;74:996.

22.

Griffin J. , Evatt B. , Wideman C. , Fernandez JA Anticoagulant protein C pathway defective in majority of thrombophilic patients . Blood 1993;82:1989.

23.

Schafer AI Essential thrombocythemia. Prog Hemostasis Thromb 1991;11:69.

24.

Triplett D. Antiphospholipid antibodies and thrombosis . Arch Pathol Lab Med 1993; 117:78.

25.

Mcneil HP , Chesterman CN , Krillis SA Immunology and clinical importance of antiphospholipid antibodies . Adv Immunol 1991;49:193.

26.

Gatineau DA , Kazmier FJ , Nichols WL , Bowie JW Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985;19:265.

27.

Roubey Ras , Pratt CW , Bruyoh JP , Winfield JB Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein I. J Clin Invest 1992;90:1100.

28.

Marciniak E. , Romond EH Impaired catalytic function of activated protein C. A new in vitro manifestation of lupus anticoagulant. Blood 1989;2426.